SunHawkVision
  • Home
  • About Sunhawk Vision Biotech
    • Company Profile
    • Awards
    • Board of Directors
    • Executive Team
    • Milestone and History
    • News
  • Research and Development
    • Technology Platform
    • Patents
    • Product Pipeline
    • Projects
  • Investor Relations
    • Financial Information
    • Corporate Governance
      • Board of Directors
      • Functional Committee
      • Major Internal Policies
      • Stakeholder Communication
      • ESG-Sustainability
      • Other Important Information Related to Corporate Governance
    • Shareholder Services
    • Material Information
  • Contact
  • 繁中
  • Menu Menu

Investor Relations

Corporate Governance

Functional Committee

Audit Committee

Our company voluntarily established the Audit Committee on September 20, 2024. The committee is composed entirely of independent directors, and its responsibilities are as follows:

  • Formulate or amend the internal control system in accordance with Article 14-1 of the Securities and Exchange Act of Taiwan.
  • The procedures for determining the effectiveness of the internal control system.
  • Formulate or amend the procedures for handling significant financial and business activities, including the acquisition or disposal of assets, derivative transactions, lending funds to others, and providing endorsements or guarantees for others, in accordance with Article 36-1 of the Securities and Exchange Act.
  • Matters involving the personal interests of directors.
  • Significant asset or derivative transactions.
  • Significant lending of funds, endorsements, or guarantees.
  • Issuance, Offering, or Private Placement of Equity Securities.
  • Appointment, dismissal, or compensation of the certified public accountant.
  • Appointment or dismissal of financial, accounting, or internal audit managers.
  • Annual financial report and semi-annual financial report.
  • Significant matters prescribed by other companies or regulatory authorities.

◾ First Audit Committee Members.

Position TitleName
Independent DirectorLIN,CHIH-HUNG
Independent DirectorLI,LING-LING
Independent DirectorYANG,HAN-CHUN

Compensation Committee

The company established a Compensation Committee on September 20, 2024.The Compensation Committee should responsibly manage its duties, faithfully execute the following powers, and submit the proposed recommendations for the Board of Directors’ discussion.

  1. Establish and regularly review policies, systems, standards, and structures for the performance evaluation and compensation of directors and executives.
  2. Continuously assess and set compensation for directors and executives.

◾ First Compensation Committee Members.

Position TitleName
Independent DirectorYANG,HAN-CHUN
Independent DirectorLIN,CHIH-HUNG
Independent DirectorLI,LING-LING

  • Board of Directors
  • Functional Committee
  • Major Internal Policies
  • Stakeholder Communication
  • ESG-Sustainability
  • Other Important Information Related to Corporate Governance

Kaohsiung Office

  • +886-7-2222660
  • info@shvbiotech.com
  • 17F-1, No.6, Siwei 3rd Road, Lingya District, Kaohsiung City 802, Taiwan

Taipei Office

  • +886-2-27114597
  • info@shvbiotech.com
  • 3F-5, No.66, Sanchong Road, Nangang District, Taipei City 115, Taiwan

© Copyright – Sunhawk Vision Biotech, Inc.

design by Morcept

© Copyright – Sunhawk Vision Biotech, Inc.
design by Morcept

Scroll to top